Predictive Value of Innovative Prognostic Markers (Gut Microbiota, Sarcopenia, Metabolic Syndrome and Obesity) on Surgical and Oncologic Results in the Management of Sporadic Colorectal Adenocarcinoma.
Clinical trial NCT03843905 · UNKNOWN
Trial details
- NCT number
- NCT03843905
- Sponsor
- University Hospital, Clermont-Ferrand
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-11-15
- Primary completion
- 2018-11-15
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.